Editor - Guang Bo Ge | Dalian Institute of Chemical Physics, Chi | 22116

Journal of Pharmacokinetics & Experimental Therapeutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Guang Bo Ge

Guang Bo Ge
Dalian Institute of Chemical Physics, Chinese Academy of Sciences


Dr. GB Ge received his B.S. degree in applied chemistry in 2003 from Dalian University of Technology, Ph.D degree in biochemical engineering in 2009 from Dalian Institute of Chemical Physics, Chinese Academy of Sciences. Now he is a professor at Dalian Institute of Chemical Physics, Chinese Academy of Sciences. His current studies are focused on drug/xenobiotics metabolism, high-throughput screening of enzyme inhibitors, drug metabolizing enzymes associated toxicity, and drug-drug/herbal interactions. In recent years, he has developed a series of specific probes or novel biosensors for sensing the activities of drug metabolizing enzymes, and all these probes have been successfully applied in drug discovery, drug metabolism and toxicological related fields. Now he is the author/coauthor of more than 100 publications in scientific journals, and his representative research achievements have been published in the top academic journals such as Journal of the American Chemical Society, Chemical Communications, ACS Applied Materials & Interfaces, Biosensors & Bioelectronics, Scientific Reports, Toxicology and Applied Pharmacology, Proteomics, Food and Chemical Toxicology, The AAPS Journal and Drug Metabolism & Disposition. He has also applied for more than 60 patents including eight international patents, and 20 of them have been authorized.

Research Interest

Xenobiotics (including drugs, herbal & food chemicals ) metabolism
Interaction between herbal/food chemicals and drug metabolizing enzymes
Probes/biosensors for drug metabolizing enzymes and their biomedical applications
High-throughput screening of enzyme inhibitors and related QSAR studies.